0000899243-23-008289.txt : 20230314 0000899243-23-008289.hdr.sgml : 20230314 20230314083011 ACCESSION NUMBER: 0000899243-23-008289 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230310 FILED AS OF DATE: 20230314 DATE AS OF CHANGE: 20230314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sorensen Mel CENTRAL INDEX KEY: 0001444783 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39114 FILM NUMBER: 23729268 MAIL ADDRESS: STREET 1: 7 RAPPS RUN DRIVE CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galera Therapeutics, Inc. CENTRAL INDEX KEY: 0001563577 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461454898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: P.O. BOX 134 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-725-1500 MAIL ADDRESS: STREET 1: P.O. BOX 134 CITY: MALVERN STATE: PA ZIP: 19355 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-10 0 0001563577 Galera Therapeutics, Inc. GRTX 0001444783 Sorensen Mel C/O GALERA THERAPEUTICS, INC. P.O. BOX 134 MALVERN PA 19355 1 1 0 0 President and CEO Common Stock 2023-03-10 4 P 0 100000 1.6812 A 332044 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.635 to $1.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. /s/ Chris Degnan, Attorney-in-Fact for J. Mel Sorensen 2023-03-14